This study demonstrated that POU2F3 expression occurs in the non-invasive stage of ductal breast carcinomas and rarely in HER2 + /HR + invasive breast carcinomas (so-called triple-positive), while it is prevalent in TNBCs. Here, ERBB2 is linked to invasive breast carcinoma.